HPLC method development for quantification of doxorubicin in cell culture and placental perfusion media

Mansi Shah, Luke Bourner, Shariq Ali, Sanaalarab Al-Enazy, Menatallah M. Youssef, Morgan Fisler, Erik Rytting

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R2values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies.

Original languageEnglish (US)
Article number9
JournalSeparations
Volume5
Issue number1
DOIs
StatePublished - Mar 1 2018

Fingerprint

High performance liquid chromatography
Cell culture
Doxorubicin
Fluorescence
Cells
Health
Proteins
Experiments
Pharmaceutical Preparations
Culture Media
Albumins

Keywords

  • Analytical method
  • Anthracycline
  • BeWo cell culture media
  • Doxorubicin
  • Fluorescence
  • High performance liquid chromatography
  • Perfusion
  • Placenta

ASJC Scopus subject areas

  • Filtration and Separation
  • Analytical Chemistry

Cite this

HPLC method development for quantification of doxorubicin in cell culture and placental perfusion media. / Shah, Mansi; Bourner, Luke; Ali, Shariq; Al-Enazy, Sanaalarab; Youssef, Menatallah M.; Fisler, Morgan; Rytting, Erik.

In: Separations, Vol. 5, No. 1, 9, 01.03.2018.

Research output: Contribution to journalArticle

Shah, Mansi ; Bourner, Luke ; Ali, Shariq ; Al-Enazy, Sanaalarab ; Youssef, Menatallah M. ; Fisler, Morgan ; Rytting, Erik. / HPLC method development for quantification of doxorubicin in cell culture and placental perfusion media. In: Separations. 2018 ; Vol. 5, No. 1.
@article{90ce86568601435b8e45914ecd395c51,
title = "HPLC method development for quantification of doxorubicin in cell culture and placental perfusion media",
abstract = "Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R2values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies.",
keywords = "Analytical method, Anthracycline, BeWo cell culture media, Doxorubicin, Fluorescence, High performance liquid chromatography, Perfusion, Placenta",
author = "Mansi Shah and Luke Bourner and Shariq Ali and Sanaalarab Al-Enazy and Youssef, {Menatallah M.} and Morgan Fisler and Erik Rytting",
year = "2018",
month = "3",
day = "1",
doi = "10.3390/separations5010009",
language = "English (US)",
volume = "5",
journal = "Separations",
issn = "2297-8739",
publisher = "Multidisciplinary Digital Publishing Institute",
number = "1",

}

TY - JOUR

T1 - HPLC method development for quantification of doxorubicin in cell culture and placental perfusion media

AU - Shah, Mansi

AU - Bourner, Luke

AU - Ali, Shariq

AU - Al-Enazy, Sanaalarab

AU - Youssef, Menatallah M.

AU - Fisler, Morgan

AU - Rytting, Erik

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R2values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies.

AB - Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R2values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies.

KW - Analytical method

KW - Anthracycline

KW - BeWo cell culture media

KW - Doxorubicin

KW - Fluorescence

KW - High performance liquid chromatography

KW - Perfusion

KW - Placenta

UR - http://www.scopus.com/inward/record.url?scp=85061306076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061306076&partnerID=8YFLogxK

U2 - 10.3390/separations5010009

DO - 10.3390/separations5010009

M3 - Article

VL - 5

JO - Separations

JF - Separations

SN - 2297-8739

IS - 1

M1 - 9

ER -